UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib

United European gastroenterology journal, 2015-10, Vol.3 (5), p.453-461

2015

Volltextzugriff (PDF)

Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A

ESMO open, 2022-10, Vol.7 (5), p.100563-100563, Article 100563

2022

Volltextzugriff (PDF)

Phase I study of BI 754111 (anti-LAG-3) plus BI 754091(anti-PD-1) in patients (pts) with advanced solid cancers, followed by expansion in pts with microsatellite stable metastatic colorectal cancer (mCRC), anti-PD-(L)1-pretreated non-small cell lung cancer (NSCLC) and other solid tumors

Annals of oncology, 2018-10, Vol.29, p.viii441-viii441

2018

Volltextzugriff (PDF)

1243TiPPhase I study of BI 754111 (anti-LAG-3) plus BI 754091(anti-PD-1) in patients (pts) with advanced solid cancers, followed by expansion in pts with microsatellite stable metastatic colorectal cancer (mCRC), anti-PD-(L)1-pretreated non-small cell lung cancer (NSCLC) and other solid tumors

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors

Clinical cancer research, 2022-03, Vol.28 (5), p.882-892

2022

Volltextzugriff (PDF)

Hydrothermally synthesized Ag decorated β-Ga2O3 heterostructures as low cost, reusable SERS substrates for the nanomolar detection of rhodamine 6G

The Journal of physics and chemistry of solids, 2023-08, Vol.179, p.111407, Article 111407

2023

Volltextzugriff (PDF)

Synthesis and DFT studies of the structure - NLO activity evaluation of 2-(4-methoxyphenyl)-1,4,5-triphenyl-2,5-dihydro-1H-imidazole

Journal of molecular structure, 2020-01, Vol.1199, p.127004, Article 127004

2020

Volltextzugriff (PDF)

Phase 1b study of pan‐AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN‐mutated advanced solid tumors

Cancer, 2023-06, Vol.129 (12), p.1919-1929

2023

Volltextzugriff (PDF)

Reversible HER2 antibody-drug conjugate–induced ocular toxicity

Canadian journal of ophthalmology, 2022-04, Vol.57 (2), p.118-126

2022

Volltextzugriff (PDF)

Cannabis use among adults undergoing cancer treatment

Cancer, 2023-11, Vol.129 (21), p.3498-3508

2023

Volltextzugriff (PDF)

Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

Cancer investigation, 2011-05, Vol.29 (4), p.325-337

2011

Volltextzugriff (PDF)

A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer

Targeted oncology, 2021-09, Vol.16 (5), p.569-589

2021

Volltextzugriff (PDF)

Quantum chemical studies on 4-(2, 6-diphenylpyridin-4-yl) phenol: An electron transport and nonlinear optical molecule

Journal of molecular structure, 2018-08, Vol.1166, p.315-320

2018

Volltextzugriff (PDF)

Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and Outcomes

Pancreas, 2016-11, Vol.45 (10), p.1432-1437

2016

Volltextzugriff (PDF)

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL

Blood, 2011-11, Vol.118 (20), p.5506-5516

2011

Volltextzugriff (PDF)

Review on digital holography techniques using digital micromirror device

Optics and lasers in engineering, 2024-06, Vol.177, p.108120, Article 108120

2024

Volltextzugriff (PDF)

Abstract 779: A phase I study of BI 754111, an anti-LAG-3 monoclonal antibody (mAb), in combination with BI 754091, an anti-PD-1 mAb: Biomarker analyses from the microsatellite stable metastatic colorectal cancer (MSS mCRC) cohort

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.779-779

2020

Volltextzugriff (PDF)

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors

Cancer research communications, 2024-04, Vol.4 (4), p.1100-1110

2024

Volltextzugriff (PDF)

A phase 1 study of TPST-1120 as a single agent and in combination with nivolumab in subjects with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3005-3005

2022

Volltextzugriff (PDF)

Abstract C027: A Phase I, dose finding study of BI 754111, an anti-LAG-3 antibody, in combination with BI 754091, an anti-PD-1 antibody, in patients with advanced solid tumors: preliminary results from the microsatellite stable (MSS) metastatic colorectal cancer (mCRC) cohort

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.C027-C027

2019

Volltextzugriff (PDF)

Estimation of radiation hazard indices along the coastal environment of Kavvayi, Kerala, India

Materials today : proceedings, 2023-06

2023

Volltextzugriff (PDF)

OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Journal of hepatology, 2024-06, Vol.80, p.S51-S52

2024

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(48)
Berichte
(1)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(15)
Humans
(11)
Oncology
(8)
Physical Sciences
(4)
Anticancer Properties
(3)
Cancer
(3)
Chemistry
(3)
Female
(3)
Gastroenterology & Hepatology
(3)
Male
(3)
Neoplasms - Drug Therapy
(3)
Patients
(3)
Safety
(3)
Tumors
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Antitumor Activity
(2)
Biochemistry & Molecular Biology
(2)
Cancer Therapies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib

Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A

Phase I study of BI 754111 (anti-LAG-3) plus BI 754091(anti-PD-1) in patients (pts) with advanced solid cancers, followed by expansion in pts with microsatellite stable metastatic colorectal cancer (mCRC), anti-PD-(L)1-pretreated non-small cell lung cancer (NSCLC) and other solid tumors

1243TiPPhase I study of BI 754111 (anti-LAG-3) plus BI 754091(anti-PD-1) in patients (pts) with advanced solid cancers, followed by expansion in pts with microsatellite stable metastatic colorectal cancer (mCRC), anti-PD-(L)1-pretreated non-small cell lung cancer (NSCLC) and other solid tumors

A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors

Hydrothermally synthesized Ag decorated β-Ga2O3 heterostructures as low cost, reusable SERS substrates for the nanomolar detection of rhodamine 6G

Synthesis and DFT studies of the structure - NLO activity evaluation of 2-(4-methoxyphenyl)-1,4,5-triphenyl-2,5-dihydro-1H-imidazole

Phase 1b study of pan‐AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN‐mutated advanced solid tumors

Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial

The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial

Reversible HER2 antibody-drug conjugate–induced ocular toxicity

Cannabis use among adults undergoing cancer treatment

Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer

Quantum chemical studies on 4-(2, 6-diphenylpyridin-4-yl) phenol: An electron transport and nonlinear optical molecule

Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and Outcomes

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Review on digital holography techniques using digital micromirror device

Abstract 779: A phase I study of BI 754111, an anti-LAG-3 monoclonal antibody (mAb), in combination with BI 754091, an anti-PD-1 mAb: Biomarker analyses from the microsatellite stable metastatic colorectal cancer (MSS mCRC) cohort

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors

A phase 1 study of TPST-1120 as a single agent and in combination with nivolumab in subjects with advanced solid tumors

Abstract C027: A Phase I, dose finding study of BI 754111, an anti-LAG-3 antibody, in combination with BI 754091, an anti-PD-1 antibody, in patients with advanced solid tumors: preliminary results from the microsatellite stable (MSS) metastatic colorectal cancer (mCRC) cohort

Estimation of radiation hazard indices along the coastal environment of Kavvayi, Kerala, India

OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Aktive Filter

Suchergebnisse filtern